Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells
- PMID: 33951643
- DOI: 10.1159/000515594
Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells
Abstract
Mood disorders are associated with chronic low-grade systemic (sterile) inflammation, with increased plasma levels of pro-inflammatory mediators targeting all tissues including the brain. Importantly, pro-inflammatory cytokines (ex., tumor-necrosis factor alpha [TNF-α], interleukin [IL]-6) regulate mood behavior and cognition by influencing neurotransmitter levels, activating stress-responsive endocrine axes, among other effects. However, the mechanisms underlying this enhanced inflammation are not well understood. There is increasing evidence indicating that impaired immunoregulatory mechanisms may play a role in this context. Patients with mood disorders (major depression [MDD] and bipolar disorder [BD]) have reduced numbers of major regulatory cells of both innate (natural killer regulatory cells and myeloid-derived suppressor cells [MDSCs]) and adaptive immune responses (CD4+CD25+FoxP3+, B regulatory cells). Dysfunctional regulatory immune cells might contribute to systemic and neuroinflammation observed in mood disorders via different mechanisms, such as: (i) failure to develop adequate stress-related responses, (ii) indirectly through microglial activation, (iii) lack of trophic support and pro-cognitive functions of T cells in the brain, and (iv) dysbiosis. In conclusion, maladaptive immunoregulatory mechanisms seem to be involved with both onset and progression of mood disorders. A deeper understanding of these mechanisms may lead to the development of new therapeutic strategies.
Keywords: Bipolar disorder; Cytokines; Inflammation; Major depressive disorder; Neuroinflammation; Regulatory T cells.
© 2021 S. Karger AG, Basel.
Similar articles
-
The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder.Mol Neurobiol. 2018 Dec;55(12):8885-8903. doi: 10.1007/s12035-018-1016-x. Epub 2018 Apr 2. Mol Neurobiol. 2018. PMID: 29611101 Review.
-
Dendritic Cells: Neglected Modulators of Peripheral Immune Responses and Neuroinflammation in Mood Disorders?Cells. 2021 Apr 19;10(4):941. doi: 10.3390/cells10040941. Cells. 2021. PMID: 33921690 Free PMC article. Review.
-
Cytokine polymorphisms in the pathophysiology of mood disorders.CNS Spectr. 2009 Aug;14(8):419-25. doi: 10.1017/s1092852900020393. CNS Spectr. 2009. PMID: 19890236
-
Immune-based strategies for mood disorders: facts and challenges.Expert Rev Neurother. 2018 Feb;18(2):139-152. doi: 10.1080/14737175.2018.1407242. Epub 2017 Nov 27. Expert Rev Neurother. 2018. PMID: 29179585 Free PMC article. Review.
-
Inflamed moods: a review of the interactions between inflammation and mood disorders.Prog Neuropsychopharmacol Biol Psychiatry. 2014 Aug 4;53:23-34. doi: 10.1016/j.pnpbp.2014.01.013. Epub 2014 Jan 25. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 24468642 Review.
Cited by
-
T cell activation and deficits in T regulatory cells are associated with major depressive disorder and severity of depression.Sci Rep. 2024 May 16;14(1):11177. doi: 10.1038/s41598-024-61865-y. Sci Rep. 2024. PMID: 38750122 Free PMC article.
-
Basic Science of Neuroinflammation and Involvement of the Inflammatory Response in Disorders of the Nervous System.Magn Reson Imaging Clin N Am. 2024 May;32(2):375-384. doi: 10.1016/j.mric.2024.01.003. Epub 2024 Feb 6. Magn Reson Imaging Clin N Am. 2024. PMID: 38555147 Review.
-
P2X7 receptor inhibition alleviates mania-like behavior independently of interleukin-1β.iScience. 2024 Feb 20;27(3):109284. doi: 10.1016/j.isci.2024.109284. eCollection 2024 Mar 15. iScience. 2024. PMID: 38444608 Free PMC article.
-
Chronic Treatment with Nigella sativa Oil Exerts Antimanic Properties and Reduces Brain Inflammation in Rats.Int J Mol Sci. 2024 Feb 2;25(3):1823. doi: 10.3390/ijms25031823. Int J Mol Sci. 2024. PMID: 38339101 Free PMC article.
-
The impact of COVID-19 on pulmonary, neurological, and cardiac outcomes: evidence from a Mendelian randomization study.Front Public Health. 2023 Dec 14;11:1303183. doi: 10.3389/fpubh.2023.1303183. eCollection 2023. Front Public Health. 2023. PMID: 38155884 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials